1-9 of 9
Ciro R Rinaldi, MD
Close
Sort by
Journal Articles

A Retrospective Real-World Study of the Current Treatment Pathways for Myelofibrosis in the UK (The REALISM UK Study)

Adam J. Mead, MD PhD, Tim Somervaille, Professor, MD, Nauman M Butt, MD, Waseem Nagi, MD FRCPath, Alastair J Whiteway, MBBS, Suriya Kirkpatrick, MD, Ciro R Rinaldi, MD PhD, Catherine Roughley, MD, Sam Ackroyd, MD, Joanne Ewing, PhDBMBS BSc FRPATH, Pratap Neelakantan, MD FRCPath, Mamta Garg, MD FRCP, FRCPath, Claire N Harrison, Professor, David Tucker, MD, Rozinder Bains, Gavin Chiu, MBBS, MRCGP, MFPM, DPM, BSc, Joe Hickey, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1671.
https://doi.org/10.1182/blood-2019-124686
Published: 2019
Journal Articles

Expression of CD47 and Calr in Myeloproliferative Neoplasms and Myelodysplastic Syndrome: Potential New Therapeutical Targets

Kristian Boasman, BSc, MSc, Matthew J Simmonds, PhD, Ciro R Rinaldi, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5031.
https://doi.org/10.1182/blood-2019-128422
Published: 2019
Journal Articles

CD47 but Not Calreticulin Is over Expressed in Patients with Myeloproliferative Neoplasms

Kristian Boasman, BSc, MSc, Matthew J Simmonds, PhD, Ciro R Rinaldi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5492.
https://doi.org/10.1182/blood-2018-99-118266
Published: 2018
Journal Articles

Preferential Nuclear Accumulation of JAK2V617F In CD34+ but Not Granulocytic, Megakaryocytic or Erythroid Cells of Patients with Philadelphia-Negative Myeloproliferative Neoplasia

Ciro R Rinaldi, MD, Paola Rinaldi, Adele Alagia, Marica Gemei, Vitalyi Senyuk, PhD, Nicola Esposito, Fabio Formiggini, Vincenzo Martinelli, Anthony R. Green, PhD, FRCP, FRCPath, Giuseppina Nucifora, Fabrizio Pane, MD
Journal: Blood
Blood (2010) 116 (21): 4089.
https://doi.org/10.1182/blood.V116.21.4089.4089
Published: 2010
Journal Articles

JAK2V617F Mutation Persists IN Blasts and Mature CELLS of Transformed- JAK2V617F-POSITIVE-MYELOPROLIFERATIVE Neoplasia: A European LEUKEMIA NET (ENL) STUDY

Ciro R Rinaldi, MD, Paola Rinaldi, Adele Alagia, Marica Gemei, Luigi Del Vecchio, MD, Bruno Martino, Giorgina Specchia, Anna Candoni, Luigi Gugliotta, MD, Alessandro M. Vannucchi, MD, Tiziano Barbui, MD, Fabrizio Pane, MD
Journal: Blood
Blood (2010) 116 (21): 4090.
https://doi.org/10.1182/blood.V116.21.4090.4090
Published: 2010
Journal Articles

GATA1 Is Over-Expressed in Essential Thrombocytemia

Ciro R. Rinaldi, MD, Donglan Li, MD, Rosanna Ciancia, MD, Marco Picardi, MD, Paola Rinaldi, Vincenzo Martinelli, MD, Giuseppina Nucifora, PhD, Fabrizio Pane, MD, Bruno Rotoli, MD
Journal: Blood
Blood (2007) 110 (11): 1534.
https://doi.org/10.1182/blood.V110.11.1534.1534
Published: 2007
Journal Articles

Liposomal Cytarabine (Depocyte®) for the Treatment of Meningeal or CNS Disease in Acute Leukemias (AL) and Non-Hodgkin Lymphomas (NHL): A Single Centre Experience.

Andrea Camera, MD, Giuseppe Cerciello, MD, Fabiana Perna, MD, Ciro R. Rinaldi, MD, Elefanti Michele, Silvia Ferrari, Bruno Rotoli, MD
Journal: Blood
Blood (2006) 108 (11): 4540.
https://doi.org/10.1182/blood.V108.11.4540.4540
Published: 2006
Journal Articles

AML1/MDS1/EVI1 Induces Essential Thrombocythemia in Mice Independently of Jak2 Mutations.

Vitalyi Senyuk, PhD, Donglan Li, MD, PhD, Raffaella Fazzina, Francesca Cattaneo, PhD, Ciro R. Rinaldi, MD, Jerome Dickstein, MD, PhD, Giuseppina Nucifora, PhD
Journal: Blood
Blood (2006) 108 (11): 3622.
https://doi.org/10.1182/blood.V108.11.3622.3622
Published: 2006
Journal Articles

Attenuated Essential Thrombocytemia Induced in Mice by the Expression of AML1/MDS1/EVI1 (AME) or an AME Mutant: Comparison between Two New Models of Myeloproliferative Disorders.

Ciro R. Rinaldi, MD, Vitaly Senyuk, PhD, Leopoldo Laricchia-Robbio, PhD, Jerome Dickstein, PhD, Giuseppina Nucifora, PhD
Journal: Blood
Blood (2006) 108 (11): 4898.
https://doi.org/10.1182/blood.V108.11.4898.4898
Published: 2006